We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boehringer to Pay $13.5 Million Settlement for Improper Off-Label Promotion
Boehringer to Pay $13.5 Million Settlement for Improper Off-Label Promotion
Boehringer Ingelheim agreed to pay $13.5 million to all 50 states and the District of Columbia to settle a lawsuit alleging the company promoted unapproved uses of prescription drugs and engaged in deceptive marketing.